167 related articles for article (PubMed ID: 2899718)
1. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy of acute pulmonary embolism: current status and future potential.
Goldhaber SZ; Meyerovitz MF; Markis JE; Kim D; Kessler CM; Sharma GV; Vaughan DE; Selwyn AP; Dawley DL; Loscalzo J
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):96B-104B. PubMed ID: 3117862
[TBL] [Abstract][Full Text] [Related]
4. Acute pulmonary embolism treated with tissue plasminogen activator.
Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator in acute pulmonary embolism.
Goldhaber SZ
Chest; 1989 May; 95(5 Suppl):282S-289S. PubMed ID: 2495913
[TBL] [Abstract][Full Text] [Related]
6. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
7. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ; Agnelli G; Levine MN
Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator and acute pulmonary embolism.
Goldhaber SZ; Kessler CM; Heit J; Markis JE; Sharma GV; Dawley DL; Meyerovitz MF; Vaughan DE; Parker JA; Come PC
J Cell Biochem; 1988 Dec; 38(4):303-12. PubMed ID: 3149283
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
Parker JA; Markis JE; Palla A; Goldhaber SZ; Royal HD; Tumeh S; Kim D; Rustgi AK; Holman BL; Kolodny GM
Radiology; 1988 Feb; 166(2):441-5. PubMed ID: 3122266
[TBL] [Abstract][Full Text] [Related]
13. Urokinase versus tissue plasminogen activator in pulmonary embolism.
Goldhaber SZ; Loscalzo J
Lancet; 1988 Oct; 2(8616):915. PubMed ID: 2902375
[No Abstract] [Full Text] [Related]
14. Thrombolysis in venous thromboembolism. An international perspective.
Goldhaber SZ
Chest; 1990 Apr; 97(4 Suppl):176S-181S. PubMed ID: 2108856
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
[TBL] [Abstract][Full Text] [Related]
16. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of treatment regimens in 58 cases with acute pulmonary embolism].
Liang Y; Yang J; Liu S
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Apr; 23(4):235-8. PubMed ID: 11778213
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
Shortell CK; Queiroz R; Johansson M; Waldman D; Illig KA; Ouriel K; Green RM
J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
